LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 124 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $37,000 | +23.3% | 18,635 | +20.5% | 0.02% | 0.0% |
| Q1 2020 | $30,000 | -53.1% | 15,459 | 0.0% | 0.02% | -40.0% |
| Q4 2019 | $64,000 | -22.9% | 15,459 | -43.9% | 0.02% | -19.4% |
| Q3 2019 | $83,000 | -52.0% | 27,538 | 0.0% | 0.03% | -50.8% |
| Q2 2019 | $173,000 | +10.9% | 27,538 | -2.0% | 0.06% | +5.0% |
| Q1 2019 | $156,000 | -25.7% | 28,100 | +42.8% | 0.06% | -20.0% |
| Q3 2018 | $210,000 | -11.0% | 19,684 | 0.0% | 0.08% | -7.4% |
| Q2 2018 | $236,000 | -35.5% | 19,684 | -53.9% | 0.08% | -35.2% |
| Q1 2018 | $366,000 | +136.1% | 42,709 | +171.4% | 0.12% | +135.8% |
| Q4 2017 | $155,000 | -20.9% | 15,736 | -1.2% | 0.05% | -25.4% |
| Q3 2017 | $196,000 | -25.2% | 15,926 | 0.0% | 0.07% | -23.7% |
| Q2 2017 | $262,000 | -3.7% | 15,926 | -30.0% | 0.09% | -21.2% |
| Q1 2016 | $272,000 | – | 22,753 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |